| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 13 |
| 1 | PROPOFOL | 13 |
| 2 | MIDAZOLAM | 11 |
| 3 | MIDAZOLAM HYDROCHLORIDE | 11 |
| 4 | SIMVASTATIN | 11 |
| 5 | FUROSEMIDE | 10 |
| 6 | ASPIRIN | 9 |
| 7 | ASPIRIN 325 MG | 9 |
| 8 | ASPIRIN 81 MG | 9 |
| 9 | ATORVASTATIN CALCIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | 1 | 0.1429 |
| 1 | IBUTILIDE FUMARATE | 1 | 0.0323 |
| 2 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0227 |
| 3 | SUFENTANIL CITRATE | 6 | 0.0046 |
| 4 | EPHEDRINE HYDROCHLORIDE | 2 | 0.0044 |
| 5 | BETAXOLOL | 2 | 0.0024 |
| 6 | VECURONIUM BROMIDE | 3 | 0.0020 |
| 7 | CASPOFUNGIN ACETATE | 3 | 0.0019 |
| 8 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 9 | ATRACURIUM BESYLATE | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 18 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 3 | General Anesthetic [EPC] | 15 |
| 4 | Atypical Antipsychotic [EPC] | 12 |
| 5 | Loop Diuretic [EPC] | 11 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 |
| 7 | Proton Pump Inhibitor [EPC] | 10 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 9 |
| 9 | Calcium Channel Blocker [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 2 | General Anesthetic [EPC] | 15 | 0.0003 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Typical Antipsychotic [EPC] | 3 | 0.0001 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 5 | 0.0001 |